Virals logo
Meeting category
Date(s)
26 Sep 2024 - 27 Sep 2024
Program Language
English
Meeting type
Virtual Meeting

Viral Infections & Inflammation Workshop 2024

Related Enduring Materials

Enduring Materials
Day 1 - Thursday, 26 September
Welcome & Opening Session -
Opening Lecture: Pathogenesis of ME/CFS
Avindra Nath, MD
National Institutes of Health, United States
Session 1: Viruses, Inflammation, and Post-Acute Sequelae: Which Mechanisms Are at Play? -
Long COVID Immunopathogenesis
Timothy Henrich, MD
University of California, San Francisco, United States
Endogenous Retroviral Elements in Lupus
Kimberly Long, PhD
ROME Therapeutics
The Interplay between CD8 T Cell Immune Activation and Endothelial Inflammation in HIV Infection: Mechanisms and Implications
Marta Catalfamo, PhD
Department of Microbiology and Immunology, School of Medicine, Georgetown University, United States
Sex and Immunity
Eileen Scully, MD, PhD
Johns Hopkins University, United States
Oral Abstract Presentation #1 - Modelling Post-acute COVID-19 Neuropathogenesis in Human Brain Organoids
Maria C. Puertas
Irsicaixa - AIDS Research Institute, Spain
Oral Abstract Presentation #2 - Glycosaminoglycans, Applications in Prevention of Severe Inflammation Induced by Viral Infection
Ma Luo
National Microbiology Laboratory, Canada
Flash Posters -
Flash Poster #1 - Antiviral and Anti‐Inflammatory Activity of Natural Compounds against Japanese Encephalitis Virus Infection via Inhibition of Viral and Host Proteins Involved in Inflammatory Pathways
Vimal K. Maurya
King George's Medical University, Lucknow, India
Flash Poster #2 - Dissemination and Implementation Research to Address Comorbidities, Coinfections and Complications Among People Living With HIV
Paul Burns
National Institutes of Health (NIH), United States
Flash Poster #3 - Relationship between Proinflammatory Cytokines and Associated Coagulopathies among COVID-19 Patients at Mulago National Hospital, Kampala
Ibrahim Ssali
Makerere University, Uganda
Flash Poster #4 - Variations in Inflammatory and Hematological Biomarkers among COVID-19 Patients with Different Disease Profiles in Uganda
Ibrahim Ssali
Makerere University, Uganda
Day 2 - Friday, 27 September
Session 2: From Bedside to Bench -
Case Study 1: Cardiometabolic Symptoms in HIV
Gerald S. Bloomfield, MD, MPH, FACC, FASE, FAHA
Associate Professor, Medicine and Global Health; Associate Director for Research, Duke Global Health Institute, Duke University, United States
Case Study 2: Progressive Multifocal Leukoencephalopathy
Irene Cortese, MD
National Institutes of Health (NIH), United States
Session 3: Therapeutic Interventions on the Horizon -
Oral-Abstract Presentation #3 - IMP3ACT: A Novel Alpha-helical Conjugate Technology Discovery Platform for Development of Broad Spectrum Antivirals
Linhai Jiang
Decoy Therapeutics, United States
Oral-Abstract Presentation #4 - Exploring Endothelial Dysfunction Led by Proinflammatory Cytokines in COVID-19: Insights from 3D Lung Microvessels On-Chip
Maria C. Puertas
Irsicaixa - AIDS Research Institute, Spain
Nirmatrelvir/Ritonavir for the Treatment of Long COVID: Findings from the Stop-Pasc Clinical Trial
Linda Geng, MD, PhD
Stanford University School of Medicine, United States
CMV in PLWH (ELICIT Study)
Peter Hunt, MD
University of California San Francisco, United States
General
What's New
  • Registration to Viral Infections & Inflammation Workshop 2024 is now open! 

  • This year the format of the workshop is virtual. You can join the workshop from anywhere.

  • The abstract portal is now closed.

About this Program

The Viral Infections & Inflammation Workshop 2024 took place as a virtual meeting from 26 - 27 September 2024.

This workshop brings together basic, translational, and clinical researchers to disseminate the latest knowledge in this area and fuel discussion on the many remaining unknowns in order to catalyze future research. 

Acute and chronic effects of viral diseases often involve immune-mediated responses, including inflammation, immune activation, and autoimmunity. Long-COVID immunopathogenesis is complex but its understanding is advancing rapidly. The consequences of immune-mediated damage in long COVID share similarities (and differences) with other post-viral diseases like Ebola and Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In the case of HIV, ongoing activation of the inflammatory response is a major concern, and immune reconstitution remains limited in some patients even long after treatment initiation. In addition to SARS-CoV-2 and HIV, other viral infections such as CMV are known to result in inflammation-related pathology. Viruses can also trigger autoimmunity. Epstein-Barr Virus is tightly linked with the onset of Multiple Sclerosis through several autoimmune mechanisms. Viral encephalitis also often has an autoimmune background. Although these few examples illustrate different viral infections with distinct clinical consequences, underlying mechanisms that drive inflammatory complications may be common. Which plausible mechanisms are at play?

Persistent inflammation, mucosal damage, coagulopathy, autoimmunity, and immune dysfunction are putative pieces of the puzzle. Common underlying mechanisms imply the possibility of employing similar therapeutic interventions, such as neutralizing antibodies, antiviral drugs, and therapeutic vaccines to eliminate the persistent virus or anti-inflammatory drugs to ameliorate chronic inflammation. Therapeutic interventions must often target both ends of the virus-immune system spectrum. Immune therapies targeting the inflammasome or virus-specific CAR-T cells, among others, are advancing toward the cure of different acute and chronic viral diseases.

Are you interested in hearing the progress in elucidating this remaining unmet need? Find out what we have learned so far, what the gaps are, and what we can do to address those in the future.

General Information 
Who Should Attend?
- Infectiologists;
- (Clinical) virologists;
- Immunologists;
- Microbiologists; and
- Researchers
Meeting Objectives
This meeting aims to:

-Provide a global platform to exchange knowledge across different disciplines involved in research on mechanisms of virus-mediated inflammation;
- Gather basic, translational, and clinical researchers to stimulate discussion on remaining unknowns;
- Foster future collaborations among participants;
- Translate the data into clinical guidance; and
- Increase the visibility of junior investigators and their research thereby facilitating a generation of future leaders in the field.
Learning Objectives
After participating in this activity, participants will be able to:

- Outline viral infections associated with aberrant inflammation and describe the underlying mechanism and clinical manifestations;
- Summarize the latest clinical data on potential therapeutic options; and
- Identify post-infection comorbidities and reflect on management options for these comorbidities.
Practical Information 

We trust that the following information will assist you in organizing your participation for the Viral Infections and Inflammation Workshop 2024.

Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the workshop is English. Translation will not be provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Program Coordinator
Support
Silver Level

Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in this field.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Ms. Gi Gi Lam at Gigi.Lam@amededu.com. 
 
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgement during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgement on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level.

Endorsers

The Viral Infections & Inflammation Workshop 2024 is endorsed by the following organizations:

Previous Editions
2023 Highlights

Hear Prof. Roger Paredes, MD, PhD (Hospital Germans Trias & IrsiCaixa AIDS Research Institute, Spain) deliver an insightful summary for clinicians on the take-home messages from the 2nd edition of the Workshop!

Language
Ratings previous edition
Overall event experience​
5.0
Content is relevant to my practice​
4.2
Content was free from commercial bias​
4.8